SitemapContact Us
닫기
Search
Advanced Search +
닫기
Quick links
Most Cited Most Read Ahead of Print Archives Go to E-submission

Perspective

Split Viewer

Blood Res 2014; 49(3):

Published online September 25, 2014

https://doi.org/10.5045/br.2014.49.3.144

© The Korean Society of Hematology

Management of hemophilia in Korea: the past, present, and future

Eun Jin Choi, M.D. Ph.D.

Author Info. +

Hemophilia Working Party, Korean Society of Hematology, Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

Go to
  1. Yoo, KY, Kim, SK, Kwon, SS, et al. Life expectancy of Korean haemophiliacs, 1991-2012. Haemophilia, 2014;20;e356-e358.
    Pubmed
  2. Berntorp, E, Boulyjenkov, V, Brettler, D, et al. Modern treatment of haemophilia. Bull World Health Organ, 1995;73;691-701.
    Pubmed
  3. Oldenburg, J, Austin, SK, Kessler, CM. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective. Haemophilia, 2014;20;17-26.
    Pubmed
  4. Hwang TJ. Annual report of Korea Hemophilia Foundation 2012. Seoul, Korea: Korea Hemophilia Foundation; 2012. p. 16-22.
  5. Powell, JS, Josephson, NC, Quon, D, et al. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood, 2012;119;3031-3037.
    Pubmed
  6. Powell, JS, Pasi, KJ, Ragni, MV, et al. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med, 2013;369;2313-2323.
    Pubmed
  7. Peyvandi, F, Garagiola, I, Seregni, S. Future of coagulation factor replacement therapy. J Thromb Haemost, 2013;11;84-98.
    Pubmed
  8. Carcao, M. Changing paradigm of prophylaxis with longer acting factor concentrates. Haemophilia, 2014;20;99-105.
    Pubmed
  9. Ahlberg, A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl, 1965;77;3-132.
    Pubmed
  10. Collins, PW, Fischer, K, Morfini, M, Blanchette, VS, Bjorkman, S. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia, 2011;17;2-10.
    Pubmed
  11. Collins, PW. Personalized prophylaxis. Haemophilia, 2012;18;131-135.
    Pubmed
  12. Yoo, KY, Choi, YM, Hwang, TJ, Choi, EJ. The efficacy of prophylaxis for children with severe hemophilia in Korea-An experience of single institute. Clin Pediatr Hematol Oncol, 2012;19;79-85.
  13. Gringeri, A, Ewenstein, B, Reininger, A. The burden of bleeding in haemophilia: is one bleed too many?. Haemophilia, 2014;20;459-463.
    Pubmed
  14. Bolton-Maggs, PH. Optimal haemophilia care versus the reality. Br J Haematol, 2006;132;671-682.
    Pubmed

Article

Perspective

Blood Res 2014; 49(3): 144-145

Published online September 25, 2014 https://doi.org/10.5045/br.2014.49.3.144

Copyright © The Korean Society of Hematology.

Management of hemophilia in Korea: the past, present, and future

Eun Jin Choi, M.D. Ph.D.

Hemophilia Working Party, Korean Society of Hematology, Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Yoo, KY, Kim, SK, Kwon, SS, et al. Life expectancy of Korean haemophiliacs, 1991-2012. Haemophilia, 2014;20;e356-e358.
      Pubmed
    2. Berntorp, E, Boulyjenkov, V, Brettler, D, et al. Modern treatment of haemophilia. Bull World Health Organ, 1995;73;691-701.
      Pubmed
    3. Oldenburg, J, Austin, SK, Kessler, CM. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective. Haemophilia, 2014;20;17-26.
      Pubmed
    4. Hwang TJ. Annual report of Korea Hemophilia Foundation 2012. Seoul, Korea: Korea Hemophilia Foundation; 2012. p. 16-22.
    5. Powell, JS, Josephson, NC, Quon, D, et al. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood, 2012;119;3031-3037.
      Pubmed
    6. Powell, JS, Pasi, KJ, Ragni, MV, et al. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med, 2013;369;2313-2323.
      Pubmed
    7. Peyvandi, F, Garagiola, I, Seregni, S. Future of coagulation factor replacement therapy. J Thromb Haemost, 2013;11;84-98.
      Pubmed
    8. Carcao, M. Changing paradigm of prophylaxis with longer acting factor concentrates. Haemophilia, 2014;20;99-105.
      Pubmed
    9. Ahlberg, A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl, 1965;77;3-132.
      Pubmed
    10. Collins, PW, Fischer, K, Morfini, M, Blanchette, VS, Bjorkman, S. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia, 2011;17;2-10.
      Pubmed
    11. Collins, PW. Personalized prophylaxis. Haemophilia, 2012;18;131-135.
      Pubmed
    12. Yoo, KY, Choi, YM, Hwang, TJ, Choi, EJ. The efficacy of prophylaxis for children with severe hemophilia in Korea-An experience of single institute. Clin Pediatr Hematol Oncol, 2012;19;79-85.
    13. Gringeri, A, Ewenstein, B, Reininger, A. The burden of bleeding in haemophilia: is one bleed too many?. Haemophilia, 2014;20;459-463.
      Pubmed
    14. Bolton-Maggs, PH. Optimal haemophilia care versus the reality. Br J Haematol, 2006;132;671-682.
      Pubmed
    Blood Res
    Volume 59 2024
    Current Issue Archives

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download